329 related articles for article (PubMed ID: 29766829)
41. Clinical implications of
Tan M; Ng IKS; Chen Z; Ban K; Ng C; Chiu L; Seah E; Lin M; Tai BC; Yan B; Ng CH; Chng WJ
J Clin Pathol; 2017 Aug; 70(8):669-676. PubMed ID: 28100593
[TBL] [Abstract][Full Text] [Related]
42. Management of patients with cytogenetically normal acute myeloid leukemia who have neither favorable nor unfavorable markers.
Walker AR; Marcucci G
J Natl Compr Canc Netw; 2014 Apr; 12(4):527-34. PubMed ID: 24717571
[TBL] [Abstract][Full Text] [Related]
43. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
[TBL] [Abstract][Full Text] [Related]
44. [AML treatment strategy based on cytogenetic abnormalities and somatic mutations].
Imai Y
Rinsho Ketsueki; 2015 Oct; 56(10):1932-41. PubMed ID: 26458431
[TBL] [Abstract][Full Text] [Related]
45. [Genetic aberrations and new treatment strategies for pediatric acute myeloid leukemia].
Shiba N
Rinsho Ketsueki; 2018; 59(10):2260-2267. PubMed ID: 30305534
[TBL] [Abstract][Full Text] [Related]
46. Cytogenetics analysis as the central point of genetic testing in acute myeloid leukemia (AML): a laboratory perspective for clinical applications.
Rosli AA; Azlan A; Rajasegaran Y; Mot YY; Heidenreich O; Yusoff NM; Moses EJ
Clin Exp Med; 2023 Aug; 23(4):1137-1159. PubMed ID: 36229751
[TBL] [Abstract][Full Text] [Related]
47. [Correlation of adult AML Npm1 mutations with prognosis and its relationship with gene mutation of FLT3 and CEBPA].
Bao LY; Wang JS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):19-24. PubMed ID: 20137111
[TBL] [Abstract][Full Text] [Related]
48. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
49. FLT3 and NPM1 mutations in myelodysplastic syndromes: Frequency and potential value for predicting progression to acute myeloid leukemia.
Bains A; Luthra R; Medeiros LJ; Zuo Z
Am J Clin Pathol; 2011 Jan; 135(1):62-9. PubMed ID: 21173125
[TBL] [Abstract][Full Text] [Related]
50. Frequency and pattern of chromosomal abnormalities in acute myeloid leukemia from Western India: A retrospective study.
Vundinti BR; Korgaonkar S; Dhangar S; Jijina F; Shanmukhaiah C
J Cancer Res Ther; 2023; 19(2):340-346. PubMed ID: 37006070
[TBL] [Abstract][Full Text] [Related]
51. [Acute myeloid leukemia. Genetic diagnostics and molecular therapy].
Schlenk RF; Döhner K; Döhner H
Internist (Berl); 2013 Feb; 54(2):171-8. PubMed ID: 23358744
[TBL] [Abstract][Full Text] [Related]
52. Characterization of somatic mutation-associated microenvironment signatures in acute myeloid leukemia patients based on TCGA analysis.
Wang J; Dao FT; Yang L; Qin YZ
Sci Rep; 2020 Nov; 10(1):19037. PubMed ID: 33149230
[TBL] [Abstract][Full Text] [Related]
53. Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.
Baldus CD; Mrózek K; Marcucci G; Bloomfield CD
Br J Haematol; 2007 Jun; 137(5):387-400. PubMed ID: 17488484
[TBL] [Abstract][Full Text] [Related]
54. [Characterizing the molecular cytogenetics in acute monocytic leukemia].
Zhou F; Chao H; Lu X; Chen T; Yang J; Jiang N; Cen L; Zhou M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jun; 36(6):556-560. PubMed ID: 31055804
[TBL] [Abstract][Full Text] [Related]
55. Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations.
Chou SC; Tang JL; Hou HA; Chou WC; Hu FC; Chen CY; Yao M; Ko BS; Huang SY; Tsay W; Chen YC; Tien HF
Leuk Res; 2014 Nov; 38(11):1278-84. PubMed ID: 25260824
[TBL] [Abstract][Full Text] [Related]
56. Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups.
Creutzig U; Zimmermann M; Reinhardt D; Rasche M; von Neuhoff C; Alpermann T; Dworzak M; Perglerová K; Zemanova Z; Tchinda J; Bradtke J; Thiede C; Haferlach C
Cancer; 2016 Dec; 122(24):3821-3830. PubMed ID: 27529519
[TBL] [Abstract][Full Text] [Related]
57. Acute myeloid leukemia with myelodysplasia-related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutations.
Devillier R; Gelsi-Boyer V; Brecqueville M; Carbuccia N; Murati A; Vey N; Birnbaum D; Mozziconacci MJ
Am J Hematol; 2012 Jul; 87(7):659-62. PubMed ID: 22535592
[TBL] [Abstract][Full Text] [Related]
58. Gene mutational pattern and expression level in 560 acute myeloid leukemia patients and their clinical relevance.
Zhu YM; Wang PP; Huang JY; Chen YS; Chen B; Dai YJ; Yan H; Hu Y; Cheng WY; Ma TT; Chen SJ; Shen Y
J Transl Med; 2017 Aug; 15(1):178. PubMed ID: 28830460
[TBL] [Abstract][Full Text] [Related]
59. Association of cup-like nuclei in blasts with FLT3 and NPM1 mutations in acute myeloid leukemia.
Park BG; Chi HS; Jang S; Park CJ; Kim DY; Lee JH; Lee JH; Lee KH
Ann Hematol; 2013 Apr; 92(4):451-7. PubMed ID: 23238897
[TBL] [Abstract][Full Text] [Related]
60. Acute Myeloid Leukaemia with Gene Mutation: A Correlation with Haematological and Immunophenotypic Characteristics and Our Experience in a Tertiary Care Cancer Center in South India.
Khera R; Ahmed F; Mundada M; Nambaru L; Murthy SS; Devig S; Rajappa SJ; Mallavarapu KM; Santa A; Kumar P
Turk Patoloji Derg; 2018; 34(2):171-174. PubMed ID: 28984348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]